# Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections

> **NCT06680544** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sheikh Zayed Medical College** · enrollment: 120 (estimated)

## Conditions studied

- Dermatophyte Infection

## Interventions

- **DRUG:** Voriconazole high dose
- **DRUG:** Voriconazole low dose

## Key facts

- **NCT ID:** NCT06680544
- **Lead sponsor:** Sheikh Zayed Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-15
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06680544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06680544, "Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06680544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*